Craig S. Gibbs

机构：Atara Biotherapeutics (United States) · ORCID：0009-0004-1874-8065

发表论文 77 篇 · 总被引 5715 次 · h-index 38

代表论文

• Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase (2003 · Gastroenterology · 被引 569)
• Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient (2003 · Journal of Hepatology · 被引 290)
• Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC) (2001 · Journal of Virology · 被引 276)
• The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro (2003 · Journal of Virology · 被引 261)
• Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1 1Gilead Sciences gratefully acknowledges the patients, investigators, and study site personnel who participated in clinical trials GS-98-437 and GS-98-438. (2003 · Gastroenterology · 被引 223)
• Cathepsin A Is the Major Hydrolase Catalyzing the Intracellular Hydrolysis of the Antiretroviral Nucleotide Phosphonoamidate Prodrugs GS-7340 and GS-9131 (2006 · Antimicrobial Agents and Chemotherapy · 被引 174)